Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Urology therapeutics Market Research Reports
Urology therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Global Nifuratel Market Insights and Forecast to 2028By QYResearch Group "...... ast by Type and by Application for the period 2017-2028.
Segment by Type
- Tablets
- Soft Capsule
- Ointment
Segment by Application
- Medical
- Experiment
By Company......" | 04-May-2022 | $4900 | |
Interstitial Cystitis (Painful Bladder Syndrome-Bladder Pain Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... , RoA, Molecule Type and Key Players provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under developme......" | 02-May-2022 | $2000 | |
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... MoA, RoA, Molecule Type and Key Players provides an overview of the Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) pipeline landscape.
The report provides comprehensive information on the therapeutics under dev......" | 02-May-2022 | $2000 | |
Membranous Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ulonephritis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Membranous Glomerulonephritis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 02-May-2022 | $2000 | |
Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ndscape.
The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 02-May-2022 | $2000 | |
IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ropathy (Berger's Disease) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for IgA Nephropathy (Berger's Disease), complete with analysis by Stage of Development, Drug Target, Mecha......" | 02-May-2022 | $2000 | |
Focal Segmental Glomerulosclerosis (FSGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... of the Focal Segmental Glomerulosclerosis (FSGS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Focal Segmental Glomerulosclerosis (FSGS), complete with analysis by Stage of De......" | 02-May-2022 | $2000 | |
Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ia Type I pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria Type I, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), R......" | 02-May-2022 | $2000 | |
Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... e report provides comprehensive information on the therapeutics under development for Renal Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report a......" | 02-May-2022 | $2500 | |
Stress Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... inence pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Stress Urinary Incontinence, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route......" | 02-May-2022 | $2000 | |
| | |||